223 related articles for article (PubMed ID: 32272101)
1. Digoxin Initiation and Outcomes in Patients with Heart Failure with Preserved Ejection Fraction.
Lam PH; Packer M; Gill GS; Wu WC; Levy WC; Zile MR; Brar V; Arundel C; Cheng Y; Singh SN; Allman RM; Fonarow GC; Ahmed A
Am J Med; 2020 Oct; 133(10):1187-1194. PubMed ID: 32272101
[TBL] [Abstract][Full Text] [Related]
2. Analysis of Outcomes in Ischemic vs Nonischemic Cardiomyopathy in Patients With Atrial Fibrillation: A Report From the GARFIELD-AF Registry.
Corbalan R; Bassand JP; Illingworth L; Ambrosio G; Camm AJ; Fitzmaurice DA; Fox KAA; Goldhaber SZ; Goto S; Haas S; Kayani G; Mantovani LG; Misselwitz F; Pieper KS; Turpie AGG; Verheugt FWA; Kakkar AK;
JAMA Cardiol; 2019 Jun; 4(6):526-548. PubMed ID: 31066873
[TBL] [Abstract][Full Text] [Related]
3. Digoxin Use and Outcomes in Patients With Heart Failure With Reduced Ejection Fraction.
Qamer SZ; Malik A; Bayoumi E; Lam PH; Singh S; Packer M; Kanonidis IE; Morgan CJ; Abdelmawgoud A; Allman RM; Fonarow GC; Ahmed A
Am J Med; 2019 Nov; 132(11):1311-1319. PubMed ID: 31150644
[TBL] [Abstract][Full Text] [Related]
4. Digoxin Initiation and Outcomes in Patients with Heart Failure (HFrEF and HFpEF) and Atrial Fibrillation.
Singh S; Moore H; Karasik PE; Lam PH; Wopperer S; Arundel C; Tummala L; Anker MS; Faselis C; Deedwania P; Morgan CJ; Zeng Q; Allman RM; Fonarow GC; Ahmed A
Am J Med; 2020 Dec; 133(12):1460-1470. PubMed ID: 32603789
[TBL] [Abstract][Full Text] [Related]
5. Digoxin Discontinuation and Outcomes in Patients With Heart Failure With Reduced Ejection Fraction.
Malik A; Masson R; Singh S; Wu WC; Packer M; Pitt B; Waagstein F; Morgan CJ; Allman RM; Fonarow GC; Ahmed A
J Am Coll Cardiol; 2019 Aug; 74(5):617-627. PubMed ID: 31370952
[TBL] [Abstract][Full Text] [Related]
6. Heart Rate and Outcomes in Hospitalized Patients With Heart Failure With Preserved Ejection Fraction.
Lam PH; Dooley DJ; Deedwania P; Singh SN; Bhatt DL; Morgan CJ; Butler J; Mohammed SF; Wu WC; Panjrath G; Zile MR; White M; Arundel C; Love TE; Blackman MR; Allman RM; Aronow WS; Anker SD; Fonarow GC; Ahmed A
J Am Coll Cardiol; 2017 Oct; 70(15):1861-1871. PubMed ID: 28982499
[TBL] [Abstract][Full Text] [Related]
7. Epidemiology and long-term outcome in outpatients with chronic heart failure in Northwestern Europe.
Fröhlich H; Rosenfeld N; Täger T; Goode K; Kazmi S; Hole T; Katus HA; Atar D; Cleland JGF; Agewall S; Clark AL; Frankenstein L; Grundtvig M
Heart; 2019 Aug; 105(16):1252-1259. PubMed ID: 30792238
[TBL] [Abstract][Full Text] [Related]
8. Prior Heart Failure Hospitalization and Outcomes in Patients with Heart Failure with Preserved and Reduced Ejection Fraction.
Malik A; Gill GS; Lodhi FK; Tummala LS; Singh SN; Morgan CJ; Allman RM; Fonarow GC; Ahmed A
Am J Med; 2020 Jan; 133(1):84-94. PubMed ID: 31336093
[TBL] [Abstract][Full Text] [Related]
9. Renin-Angiotensin System Inhibition and Lower 30-Day All-Cause Readmission in Medicare Beneficiaries with Heart Failure.
Sanam K; Bhatia V; Bajaj NS; Gaba S; Morgan CJ; Fonarow GC; Butler J; Deedwania P; Prabhu SD; Wu WC; White M; Love TE; Aronow WS; Fletcher RD; Allman RM; Ahmed A
Am J Med; 2016 Oct; 129(10):1067-73. PubMed ID: 27262781
[TBL] [Abstract][Full Text] [Related]
10. Digoxin and prognosis of heart failure in older patients with preserved ejection fraction: Importance of heart rate. Results from an observational and multicenter study.
Llàcer P; Núñez J; Bayés-Genís A; Conde Martel A; Cabanes Hernández Y; Díez Manglano J; Álvarez Rocha P; Soler Rangel L; Gómez Del Olmo V; Manzano L; Montero Pérez-Barquero M
Eur J Intern Med; 2019 Feb; 60():18-23. PubMed ID: 30360944
[TBL] [Abstract][Full Text] [Related]
11. Digoxin and 30-Day All-Cause Readmission in Long-Term Care Residents Hospitalized for Heart Failure.
Sheriff HM; Thogaripally MR; Panjrath G; Arundel C; Zeng Q; Fonarow GC; Butler J; Fletcher RD; Morgan C; Blackman MR; Deedwania P; Love TE; Aronow WS; Anker SD; Allman RM; Ahmed A
J Am Med Dir Assoc; 2017 Sep; 18(9):761-765. PubMed ID: 28501416
[TBL] [Abstract][Full Text] [Related]
12. Comparison of one-year outcome (death and rehospitalization) in hospitalized heart failure patients with left ventricular ejection fraction >50% versus those with ejection fraction <50%.
Ezekowitz JA; Lee DS; Tu JV; Newman AM; McAlister FA
Am J Cardiol; 2008 Jul; 102(1):79-83. PubMed ID: 18572040
[TBL] [Abstract][Full Text] [Related]
13. In-hospital and 1-year outcomes of acute heart failure patients according to presentation (de novo vs. worsening) and ejection fraction. Results from IN-HF Outcome Registry.
Senni M; Gavazzi A; Oliva F; Mortara A; Urso R; Pozzoli M; Metra M; Lucci D; Gonzini L; Cirrincione V; Montagna L; Di Lenarda A; Maggioni AP; Tavazzi L;
Int J Cardiol; 2014 May; 173(2):163-9. PubMed ID: 24630337
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of atrial fibrillation and severity of symptoms of heart failure in patients with low gradient aortic stenosis and preserved left ventricular ejection fraction.
Moretti M; Fabris E; Morosin M; Merlo M; Barbati G; Pinamonti B; Gatti G; Pappalardo A; Sinagra G
Am J Cardiol; 2014 Dec; 114(11):1722-8. PubMed ID: 25316349
[TBL] [Abstract][Full Text] [Related]
15. Digoxin use and lower risk of 30-day all-cause readmission in older patients with heart failure and reduced ejection fraction receiving β-blockers.
Lam PH; Bhyan P; Arundel C; Dooley DJ; Sheriff HM; Mohammed SF; Fonarow GC; Morgan CJ; Aronow WS; Allman RM; Waagstein F; Ahmed A
Clin Cardiol; 2018 Mar; 41(3):406-412. PubMed ID: 29569405
[TBL] [Abstract][Full Text] [Related]
16. Heart failure with preserved ejection fraction has a better long-term prognosis than heart failure with reduced ejection fraction in old patients in a 5-year follow-up retrospective study.
Kontogeorgos S; Thunström E; Johansson MC; Fu M
Int J Cardiol; 2017 Apr; 232():86-92. PubMed ID: 28100428
[TBL] [Abstract][Full Text] [Related]
17. Impact of digoxin on risk of death in heart failure patients treated with b-blockers. Results from Polish part of ESC Heart Failure Long-Term Registry.
Migaj J; Kałużna-Oleksy M; Nessler J; Opolski G; Crespo-Leiro MG; Maggioni AP; Grajek S; Ponikowski P; Drożdż J; Straburzyńska-Migaj E
Kardiol Pol; 2018; 76(7):1064-1072. PubMed ID: 29476617
[TBL] [Abstract][Full Text] [Related]
18. An evidence-based review of recent advances in therapy for heart failure with reduced ejection fraction (HFrEF).
Raj L; Adhyaru B
Postgrad Med J; 2016 Dec; 92(1094):726-734. PubMed ID: 27708003
[TBL] [Abstract][Full Text] [Related]
19. Renin-Angiotensin Inhibition and Outcomes in HFrEF and Advanced Kidney Disease.
Patel S; Lam PH; Kanonidis EI; Ahmed AA; Raman VK; Wu WC; Rossignol P; Arundel C; Faselis C; Kanonidis IE; Deedwania P; Allman RM; Sheikh FH; Fonarow GC; Pitt B; Ahmed A
Am J Med; 2023 Jul; 136(7):677-686. PubMed ID: 37019372
[TBL] [Abstract][Full Text] [Related]
20. MY APPROACH to treating heart failure with reduced ejection fraction.
Greenberg BH
Trends Cardiovasc Med; 2014 Nov; 24(8):367-8. PubMed ID: 25267506
[No Abstract] [Full Text] [Related]
[Next] [New Search]
